ROS1 Gene
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What the ROS1 Gene Means in Everyday Medical Language
The ROS1 gene is a part of our DNA that tells cells how to make a protein involved in sending signals inside the cell and helping it grow. Normally, this process helps cells develop and function properly. However, in some cancers, the ROS1 gene can change or fuse with other genes, creating a new, abnormal gene fusion. This fusion can cause cancer cells to grow and divide uncontrollably.
Why ROS1 Gene Changes Matter in Cancer Care
Finding a ROS1 gene fusion in a cancer is important because it can guide treatment choices. Certain targeted cancer medicines, like Augtyro (also called repotrectinib) and crizotinib, are designed to block the signals from these abnormal ROS1 proteins. By doing this, these drugs may slow or stop the cancer’s growth. These treatments are different from traditional chemotherapy because they focus specifically on the cancer’s unique genetic changes.
What Patients Might See or Hear About ROS1
Patients may hear about the ROS1 gene during genetic testing of their tumor or when doctors discuss treatment options. The term might appear in medical reports, treatment plans, or conversations about targeted therapies. If a cancer has a ROS1 fusion, doctors might mention drugs like Augtyro or crizotinib as possible treatments. However, not all cancers have ROS1 changes, so these drugs are only used when testing confirms their presence.
Where the Term ROS1 Gene Might Appear
The ROS1 gene may be mentioned in pathology reports that describe genetic testing results, treatment plans that include targeted therapies, or clinical trial information. It can also appear in drug information sheets or educational materials about personalized cancer treatments. Seeing the term in these places usually relates to the cancer’s genetic makeup and possible treatment options.
What ROS1 Gene Does Not Automatically Mean
Finding the term ROS1 gene or ROS1 fusion does not mean a cancer is easy or hard to treat, nor does it guarantee that targeted drugs will work. It also does not mean the patient will definitely receive these treatments. Many factors, including overall health, cancer type, and previous treatments, influence treatment decisions. The presence of a ROS1 fusion is one piece of information among many.
How Doctors Use ROS1 Gene Testing in Care
Doctors often test cancers for ROS1 gene fusions to help decide if targeted therapies might be effective. This testing is part of a personalized approach to cancer care, where treatments are chosen based on the cancer’s genetic features. If a ROS1 fusion is found, doctors may consider drugs like Augtyro or crizotinib, which block the abnormal signals from the fusion protein. These drugs belong to a group called tyrosine kinase inhibitors.
Common Questions Patients Can Ask Their Care Team
Patients might ask: What does it mean that my cancer has a ROS1 gene fusion? How do drugs like Augtyro or crizotinib work for my cancer? What side effects should I expect? Are there other treatment options? How will we know if the treatment is working? Asking these questions can help patients understand their care and feel more involved in decisions.
How to Read the Term ROS1 Gene in Context
It’s important to understand that the ROS1 gene is not a diagnosis by itself but a part of the cancer’s genetic profile. When you see ROS1 mentioned, ask your care team how it applies to your specific situation. This helps avoid confusion and ensures you get information relevant to your care.
Safety and Context
This information is educational and does not replace medical advice. Each patient’s cancer and health are unique. Treatment decisions should always be made with your healthcare team, who can explain what ROS1 gene testing means for you and what treatments might be safe and appropriate.
Next Steps for Patients and Caregivers
If you see the term ROS1 gene in your medical records or hear it during discussions, the best next step is to ask your care team what it means for your diagnosis and treatment. Understanding how this gene change fits into your care can help you make informed decisions and feel more confident about your treatment plan.
Sources
Public source information used for this glossary entry includes: